RIGEL PHARMACEUTICALS INC shareholders Q3 2023

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NATIXIS 37,500$40,5000.00%
SG Americas Securities, LLC 31,493$340.00%
PRICE T ROWE ASSOCIATES INC /MD/ 100,246$1090.00%
NEW YORK STATE COMMON RETIREMENT FUND 33,727$360.00%
NISA INVESTMENT ADVISORS, LLC 135$1460.00%
MARSHALL WACE, LLP 36,017$38,8980.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 81,884$88,4350.00%
DEUTSCHE BANK AG\ 78,922$85,2360.00%
CITIGROUP INC 99$1070.00%
HSBC HOLDINGS PLC 21,103$22,6860.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 864,205$933,3410.00%
GOLDMAN SACHS GROUP INC 585,217$632,0340.00%
Invesco Ltd. 93,072$100,5180.00%
AMALGAMATED BANK 24,396$260.00%
MACKENZIE FINANCIAL CORP 33,119$33,7810.00%
NATIONAL BANK OF CANADA /FI/ 4,000$4,1200.00%
WOLVERINE TRADING, LLC 14,900$16,0920.00%
ProShare Advisors LLC 22,234$24,0130.00%
BlackRock Inc. 14,413,495$15,566,5730.00%
Bank of New York Mellon Corp 558,062$602,7070.00%
External links

This page lists RIGEL PHARMACEUTICALS INC's shareholders in Q3 2023. To view RIGEL PHARMACEUTICALS INC's shareholder history, click here.